Crohn's Disease Clinical Trials in Dayton, Ohio

4 studies are recruiting for crohn's disease in Dayton, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 month…

    Stage
    Phase 4
    Ages
    18 to 80
    Site
    DSI Research Northridge LLC, Dayton, Ohio
    Locations
    101 in total
    Run by
    Takeda

    See if you can join NCT06581328 on ClinicalTrials.gov

  2. A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants with Crohn's Disease (CD) at the end of maintenance therapy (Week 52) among participants who were in clinical response to guselkumab at Week 12.

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    The Children's Medical Center of Dayton, Dayton, Ohio
    Locations
    85 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT05923073 on ClinicalTrials.gov

  3. A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

    Study participants will be screened during the platform study and randomly assigned to receive mirikizumab or another intervention. The purpose of the mirikizumab study is to evaluate efficacy, safety, tolerability, and how well mirikizumab absorbs into the body of pediatric participants with Crohn…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    Childrens Medical Center, Dayton, Ohio
    Locations
    81 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT05509777 on ClinicalTrials.gov

  4. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study duration may be up to 35 …

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    DSI Research, LLC-Site Number: 8400115, Dayton, Ohio
    Locations
    301 in total
    Run by
    Sanofi

    See if you can join NCT07184931 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.